GlaxoSmithKline plc (GSK) Given Consensus Recommendation of “Hold” by Analysts
GlaxoSmithKline plc (LON:GSK) has received an average rating of “Hold” from the twenty-two analysts that are covering the stock, MarketBeat reports. Four investment analysts have rated the stock with a sell recommendation, eleven have given a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month price target among brokers that have covered the stock in the last year is GBX 1,689.48 ($22.21).
A number of analysts recently issued reports on the stock. Jefferies Group LLC lifted their price target on shares of GlaxoSmithKline plc from GBX 1,800 ($23.67) to GBX 1,900 ($24.98) and gave the stock a “buy” rating in a research note on Friday, June 16th. Liberum Capital restated a “buy” rating and issued a GBX 1,900 ($24.98) price target on shares of GlaxoSmithKline plc in a research note on Wednesday, June 14th. Deutsche Bank AG restated a “hold” rating and issued a GBX 1,720 ($22.61) price target on shares of GlaxoSmithKline plc in a research note on Friday, June 30th. J P Morgan Chase & Co restated a “neutral” rating and issued a GBX 1,750 ($23.01) price target on shares of GlaxoSmithKline plc in a research note on Friday, June 30th. Finally, Barclays PLC restated an “equal weight” rating and issued a GBX 1,550 ($20.38) price target on shares of GlaxoSmithKline plc in a research note on Monday, July 3rd.
In related news, insider Patrick Vallance acquired 861 shares of the business’s stock in a transaction that occurred on Friday, July 14th. The shares were acquired at an average cost of GBX 1,618 ($21.27) per share, for a total transaction of £13,930.98 ($18,315.78). Also, insider Manvinder Singh Banga acquired 2,267 shares of the business’s stock in a transaction that occurred on Wednesday, July 26th. The shares were bought at an average price of GBX 1,599 ($21.02) per share, for a total transaction of £36,249.33 ($47,658.86). Over the last 90 days, insiders have purchased 3,153 shares of company stock worth $5,055,853.
GlaxoSmithKline plc (GSK) opened at 1522.00 on Thursday. The stock has a 50 day moving average of GBX 1,500.18 and a 200 day moving average of GBX 1,586.54. The firm’s market cap is GBX 74.40 billion. GlaxoSmithKline plc has a one year low of GBX 1,444.00 and a one year high of GBX 1,724.50.
The business also recently disclosed a dividend, which will be paid on Thursday, October 12th. Investors of record on Thursday, August 10th will be paid a dividend of GBX 19 ($0.25) per share. This represents a dividend yield of 1.23%. The ex-dividend date of this dividend is Thursday, August 10th.
About GlaxoSmithKline plc
GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases.
Receive News & Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related companies with MarketBeat.com's FREE daily email newsletter.